Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer UseZacks Investment Research • 01/15/24
Merck Animal Health's Fourth Veterinary Wellbeing Study Indicates Progress in Addressing Mental Health Challenges Among Veterinary TeamsPRNewsWire • 01/15/24
FDA Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical CancerBusiness Wire • 01/12/24
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology SpaceInvestors Business Daily • 01/12/24
HARPOON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Harpoon Therapeutics, Inc. - HARPBusiness Wire • 01/10/24
iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must WatchSeeking Alpha • 01/10/24
Merck & Co., Inc. (MRK) Presents at JPMorgan 42nd Annual Healthcare Conference (Transcript)Seeking Alpha • 01/09/24
Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?Investors Business Daily • 01/08/24
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In ValueInvestors Business Daily • 01/08/24